Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (301126) - Total Liabilities

Latest as of March 2026: CN¥4.79 Billion CNY ≈ $700.86 Million USD

Based on the latest financial reports, Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (301126) has total liabilities worth CN¥4.79 Billion CNY (≈ $700.86 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd - Total Liabilities Trend (2019–2025)

This chart illustrates how Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd's total liabilities have evolved over time, based on quarterly financial data. See 301126 working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd Competitors by Total Liabilities

The table below lists competitors of Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Western New England Bancorp Inc NASDAQ:WNEB	USA	$2.49 Billion
HL Corp Shenzhen SHE:002105	China	CN¥773.02 Million
Zhejiang Shapuaisi Pharmaceutical Co Ltd SHG:603168	China	CN¥513.25 Million
Dabaco VN:DBC	Vietnam	₫7.91 Trillion
Bold Eagle Acquisition Corp. Class A Ordinary Shares NASDAQ:BEAG	USA	$9.73 Million
Trailblazer Acquisition Corp. Class A Ordinary Shares NASDAQ:BLZR	USA	$11.79 Million
GABIA Inc KQ:079940	Korea	₩255.55 Billion
Best SA WAR:BST	Poland	zł1.79 Billion

Liability Composition Analysis (2019–2025)

This chart breaks down Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 301126 market cap overview.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.01	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	3.21	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.75	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (2019–2025)

The table below shows the annual total liabilities of Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd from 2019 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥4.74 Billion ≈ $694.20 Million	+9.57%
2024-12-31	CN¥4.33 Billion ≈ $633.54 Million	+23.84%
2023-12-31	CN¥3.50 Billion ≈ $511.58 Million	+65.36%
2022-12-31	CN¥2.11 Billion ≈ $309.37 Million	+60.76%
2021-12-31	CN¥1.32 Billion ≈ $192.45 Million	+13.33%
2020-12-31	CN¥1.16 Billion ≈ $169.82 Million	+11.82%
2019-12-31	CN¥1.04 Billion ≈ $151.86 Million	--

About Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd

SHE:301126 China Pharmaceutical Retailers

Market Cap

$278.33 Million

CN¥1.90 Billion CNY

Market Cap Rank

#15285 Global

#4500 in China

Share Price

CN¥9.26

Change (1 day)

-0.11%

52-Week Range

CN¥9.26 - CN¥14.35

All Time High

CN¥36.14